Following earlier chemotherapy dosing incidents in South Australia (and the release of an independent report), NSW Health is reported to have has launched an inquiry into the incorrect dosing of head and neck cancer patients at Sydney’s St Vincent’s Hospital.

The review will be led by chief executive of the Cancer Institute of NSW, Professor David Currow, with support from the Clinical Excellence Commission (CEC) and the Ministry of Health. It will cover the adequacy, timeliness and scope of St Vincent’s Hospital’s response and identify areas for system improvement.

Media reports suggest that patients who received the dosage have only just been notified, despite the hospital having known of the breach of its protocol for at least three years.

One thought on “Chemotherapy error in NSW

Comments are closed.